Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Accept all cookies Reject all non-essential cookies Find out more

Ashmolean turns red for World Encephalitis Day

Clinical Neurology

Our researchers are tackling the devastating brain condition encephalitis.

© John Cairns

Tuesday 22 February was World Encephalitis Day, and the Ashmolean Museum in Oxford took part in 'Light up a Landmark' to help raise awareness right across the world. 

Researchers Sofija Paneva, Laurissa Havins and Christine Strippel from the Oxford Autoimmune Neurology Group outside the Ashmolean Museum lit up red for World Encephalitis Day 2023© John Cairns

Encephalitis is an inflammation of the brain. It is caused by an infection or the immune system attacking the brain in error. It can have a high death rate and survivors might be left with an acquired brain injury and life-changing consequences. Early diagnosis and treatment can save lives and improve outcomes.

Professor Sarosh Irani leads our Autoimmune Neurology Group. They work with patients and their carers, to better understand diagnosis, the underlying cause of the diseases and patient outcomes. 

The team is also involved in improving awareness of encephalitis among the general public and fellow healthcare professionals in the hope that it can eventually lead to a quicker pathway for patients to get the care they need.

Pictured are researchers Sofija Paneva, Laurissa Havins and Christine Strippel.

Read more on the University of Oxford website.

Similar stories

European Platform for Neurodegenerative Diseases launches repository of cohorts for researchers

The new Cohort Catalogue will facilitate discovery of over 60 neurodegeneration research cohorts from 17 countries across Europe

Bioelectronic implant offers an intelligent therapy to treat incontinence

The first participants in a clinical trial of a bioelectrical therapy to treat incontinence have received their 'smart' bioelectronic implants.

Direct evidence of reduced NMDA receptors in people with form of encephalitis

NMDAR-antibody encephalitis is an autoimmune brain condition caused by patient’s own antibodies that bind to NMDA (N-Methyl-D-Aspartate) receptors in the synapses between nerve cells.

The risk of seizures and epilepsy is higher after COVID than after the flu

New study shows clinical symptoms for Alzheimer’s can be predicted in preclinical models

Establishing preclinical models of Alzheimer’s that reflect in-life clinical symptoms of each individual is a critically important goal, yet so far it has not been fully realised. A new collaborative study from the University of Oxford has demonstrated that clinical vulnerability to an abnormally abundant protein in Alzheimer’s brain is in fact reflected in individual patient induced pluripotent stem cell-derived cortical neurons.

New insights gained into how the brain encodes information about the world

Scientists have developed a new way to test the theory that active neurons can change what they signal in the world, rather than keeping a stable correspondence to things (such as a features of an object, or ideas).